頭頸部扁平上皮癌肺転移例に対するTPF療法変法の検討（第2報）

DOI Web Site 参考文献16件

書誌事項

タイトル別名
  • Modified TPF Chemotherapy for Pulmonary Metastases from Squamous Cell Carcinoma of the Head and Neck
  • リンショウ アタマ ケイブ ヘンペイ ジョウヒガン ハイ テンイレイ ニ タイスル TPF リョウホウ ヘンポウ ノ ケントウ(ダイ2ホウ)

この論文をさがす

抄録

We report herein on 15 cases of pulmonary metastases from squamous cell carcinoma of the head and neck (SCCHN) treated with modified TPF chemotherapy (docetaxel combined with nedaplatin and 5-FU). TPF chemotherapy is known as a neoajuvant chemotherapy regimen. We modified the TPF chemotherapy using nedaplatin as a substitute for cisplatin. We tried 4 courses of modified TPF chemotherapy every 3 weeks, docetaxel 60 mg/m2 on day 1; nedaplatin 75 mg/m2 on day 1 and 5-FU 1000 mg/body by continuous infusion on days 1 to 4. 11 patients received 4 courses, and the remaining of 4 patients recieved 1-3 courses because of their poor general condition. Of the 15 patients, 13 were males and 2 were females with ages ranging from 43 to 73 years (mean, 59.1 yr). Two of the primary sites were in the nasopharynx, 2 in orophanrynx, 4 in the hypopharynx, 2 in the larynx and 4 in the oral cavity. Clinically there were 7 complete responders, 4 partial responders, 2 with no change, and 2 with progressive disease. The mean overall survival was 46.5 months. TPF chemotherapy may improve the overall survival.<br>

収録刊行物

参考文献 (16)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ